nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—CHRM3—muscle of abdomen—Crohn's disease	0.0568	0.219	CbGeAlD
Promazine—HTR2A—enteric nervous system—Crohn's disease	0.0532	0.205	CbGeAlD
Promazine—HTR2A—myenteric nerve plexus—Crohn's disease	0.0403	0.156	CbGeAlD
Promazine—CHRM5—epithelium—Crohn's disease	0.0121	0.0467	CbGeAlD
Promazine—CHRM5—skin of body—Crohn's disease	0.0115	0.0444	CbGeAlD
Promazine—ADRA1D—epithelium—Crohn's disease	0.0108	0.0417	CbGeAlD
Promazine—CHRM3—smooth muscle tissue—Crohn's disease	0.00652	0.0251	CbGeAlD
Promazine—ADRA1A—epithelium—Crohn's disease	0.00621	0.024	CbGeAlD
Promazine—CHRM3—digestive system—Crohn's disease	0.00515	0.0199	CbGeAlD
Promazine—HRH1—epithelium—Crohn's disease	0.00481	0.0185	CbGeAlD
Promazine—CYP2C19—digestive system—Crohn's disease	0.00478	0.0185	CbGeAlD
Promazine—ADRA1A—lymphoid tissue—Crohn's disease	0.00478	0.0185	CbGeAlD
Promazine—HRH1—smooth muscle tissue—Crohn's disease	0.00463	0.0179	CbGeAlD
Promazine—HRH1—mammalian vulva—Crohn's disease	0.00417	0.0161	CbGeAlD
Promazine—ADRA2A—mammalian vulva—Crohn's disease	0.0041	0.0158	CbGeAlD
Promazine—HTR2A—epithelium—Crohn's disease	0.00401	0.0155	CbGeAlD
Promazine—CYP1A2—digestive system—Crohn's disease	0.00391	0.0151	CbGeAlD
Promazine—HTR2A—smooth muscle tissue—Crohn's disease	0.00387	0.0149	CbGeAlD
Promazine—Desipramine—SLC22A4—Crohn's disease	0.00374	0.182	CrCbGaD
Promazine—CYP2C9—digestive system—Crohn's disease	0.00371	0.0143	CbGeAlD
Promazine—HRH1—digestive system—Crohn's disease	0.00366	0.0141	CbGeAlD
Promazine—Imipramine—SLC22A4—Crohn's disease	0.00317	0.154	CrCbGaD
Promazine—Diphenhydramine—SLC22A5—Crohn's disease	0.00316	0.153	CrCbGaD
Promazine—HTR2A—digestive system—Crohn's disease	0.00305	0.0118	CbGeAlD
Promazine—CYP3A4—digestive system—Crohn's disease	0.00283	0.0109	CbGeAlD
Promazine—Desipramine—SLC22A5—Crohn's disease	0.00281	0.136	CrCbGaD
Promazine—HRH1—lymph node—Crohn's disease	0.00209	0.00806	CbGeAlD
Promazine—ADRA2A—lymph node—Crohn's disease	0.00205	0.00792	CbGeAlD
Promazine—Oxcarbazepine—ALB—Crohn's disease	0.00169	0.0819	CrCbGaD
Promazine—Acepromazine—ALB—Crohn's disease	0.00127	0.0619	CrCbGaD
Promazine—Thioproperazine—ALB—Crohn's disease	0.00125	0.0605	CrCbGaD
Promazine—Pipotiazine—ALB—Crohn's disease	0.00123	0.0595	CrCbGaD
Promazine—Clomipramine—ALB—Crohn's disease	0.000969	0.047	CrCbGaD
Promazine—Chlorpromazine—ALB—Crohn's disease	0.000664	0.0323	CrCbGaD
Promazine—Amitriptyline—ALB—Crohn's disease	0.000657	0.0319	CrCbGaD
Promazine—ADRA1D—Signaling by GPCR—TYK2—Crohn's disease	0.000145	0.000202	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—IL3—Crohn's disease	0.000144	0.0002	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	0.000144	0.000199	CbGpPWpGaD
Promazine—DRD4—Signaling by GPCR—CXCL8—Crohn's disease	0.000142	0.000198	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	0.000141	0.000196	CbGpPWpGaD
Promazine—DRD1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000141	0.000196	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	0.000141	0.000195	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—CXCL8—Crohn's disease	0.00014	0.000195	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—JAK2—Crohn's disease	0.00014	0.000195	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—SMAD3—Crohn's disease	0.00014	0.000194	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	0.00014	0.000194	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—RASGRP1—Crohn's disease	0.00014	0.000194	CbGpPWpGaD
Promazine—ADRA1D—GPCR downstream signaling—CXCL8—Crohn's disease	0.000139	0.000193	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—JAK2—Crohn's disease	0.000139	0.000192	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	0.000138	0.000192	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—FADS1—Crohn's disease	0.000138	0.000192	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	0.000138	0.000192	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000138	0.000191	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	0.000137	0.00019	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—IL2RA—Crohn's disease	0.000137	0.00019	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—MTMR3—Crohn's disease	0.000137	0.00019	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—RIPK2—Crohn's disease	0.000136	0.000189	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	0.000136	0.000189	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	0.000135	0.000188	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—IL2RA—Crohn's disease	0.000135	0.000188	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—CXCL8—Crohn's disease	0.000134	0.000187	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	0.000134	0.000186	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—RIPK2—Crohn's disease	0.000134	0.000186	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000133	0.000185	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—SMAD3—Crohn's disease	0.000133	0.000185	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	0.000133	0.000185	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—IL3—Crohn's disease	0.000133	0.000185	CbGpPWpGaD
Promazine—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	0.000132	0.000184	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	0.000132	0.000183	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	0.000132	0.000183	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—SMAD3—Crohn's disease	0.000131	0.000183	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	0.000131	0.000182	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—IL3—Crohn's disease	0.000131	0.000182	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—IL3—Crohn's disease	0.000131	0.000181	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—IL3—Crohn's disease	0.00013	0.000181	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—IL3—Crohn's disease	0.00013	0.00018	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—GPX4—Crohn's disease	0.000129	0.00018	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—IL2RA—Crohn's disease	0.000129	0.00018	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	0.000129	0.000179	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—IL3—Crohn's disease	0.000128	0.000178	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	0.000128	0.000178	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—IL3—Crohn's disease	0.000128	0.000178	CbGpPWpGaD
Promazine—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	0.000127	0.000176	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	0.000127	0.000176	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—CXCL8—Crohn's disease	0.000126	0.000176	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	0.000126	0.000175	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	0.000126	0.000175	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	0.000126	0.000175	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	0.000126	0.000175	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000126	0.000175	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	0.000125	0.000174	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—GCKR—Crohn's disease	0.000125	0.000174	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	0.000124	0.000173	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	0.000124	0.000172	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—IL2RA—Crohn's disease	0.000123	0.000171	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	0.000122	0.000169	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—IL2RA—Crohn's disease	0.000122	0.000169	CbGpPWpGaD
Promazine—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	0.000121	0.000168	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	0.000121	0.000167	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	0.00012	0.000167	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL3—Crohn's disease	0.000119	0.000165	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	0.000117	0.000162	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—SOCS1—Crohn's disease	0.000117	0.000162	CbGpPWpGaD
Promazine—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000116	0.00016	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	0.000115	0.00016	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	0.000115	0.00016	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	0.000115	0.000159	CbGpPWpGaD
Promazine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000115	0.000159	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	0.000115	0.000159	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	0.000115	0.000159	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—SOCS1—Crohn's disease	0.000114	0.000159	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.000114	0.000159	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	0.000114	0.000158	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	0.000114	0.000158	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	0.000114	0.000158	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	0.000114	0.000158	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	0.000113	0.000157	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	0.000113	0.000156	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	0.000112	0.000156	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	0.000112	0.000156	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—TYK2—Crohn's disease	0.000111	0.000154	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	0.00011	0.000152	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	0.000109	0.000152	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	0.000109	0.000152	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—TYK2—Crohn's disease	0.000109	0.000151	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	0.000109	0.000151	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	0.000108	0.00015	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	0.000107	0.000149	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	0.000107	0.000149	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—FADS1—Crohn's disease	0.000107	0.000148	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000107	0.000148	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—JAK2—Crohn's disease	0.000106	0.000147	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	0.000106	0.000147	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	0.000105	0.000146	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000105	0.000146	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000105	0.000145	CbGpPWpGaD
Promazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000105	0.000145	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	0.000104	0.000145	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	0.000104	0.000145	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	0.000104	0.000145	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000104	0.000145	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—JAK2—Crohn's disease	0.000104	0.000144	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	0.000104	0.000144	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	0.000104	0.000144	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	0.000103	0.000144	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000103	0.000143	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000103	0.000142	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	0.000102	0.000142	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	0.000102	0.000142	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	0.000101	0.00014	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—SMAD3—Crohn's disease	0.000101	0.00014	CbGpPWpGaD
Promazine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.0001	0.000139	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GPX4—Crohn's disease	9.99e-05	0.000139	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	9.95e-05	0.000138	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	9.9e-05	0.000137	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—SMAD3—Crohn's disease	9.88e-05	0.000137	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	9.85e-05	0.000137	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	9.81e-05	0.000136	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	9.72e-05	0.000135	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	9.69e-05	0.000135	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	9.67e-05	0.000134	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—TYK2—Crohn's disease	9.66e-05	0.000134	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GCKR—Crohn's disease	9.65e-05	0.000134	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	9.54e-05	0.000132	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—TYK2—Crohn's disease	9.53e-05	0.000132	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	9.52e-05	0.000132	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	9.5e-05	0.000132	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	9.49e-05	0.000132	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	9.47e-05	0.000131	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	9.44e-05	0.000131	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	9.35e-05	0.00013	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	9.32e-05	0.000129	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—IL2RA—Crohn's disease	9.32e-05	0.000129	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—JAK2—Crohn's disease	9.21e-05	0.000128	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	9.17e-05	0.000127	CbGpPWpGaD
Promazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	9.15e-05	0.000127	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—IL2RA—Crohn's disease	9.15e-05	0.000127	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—TYK2—Crohn's disease	9.12e-05	0.000127	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	9.12e-05	0.000127	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—JAK2—Crohn's disease	9.09e-05	0.000126	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	9.09e-05	0.000126	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	9.01e-05	0.000125	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	9e-05	0.000125	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	8.98e-05	0.000125	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.94e-05	0.000124	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—JAK2—Crohn's disease	8.7e-05	0.000121	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—TYK2—Crohn's disease	8.69e-05	0.000121	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	8.66e-05	0.00012	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	8.58e-05	0.000119	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—CXCL8—Crohn's disease	8.41e-05	0.000117	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	8.34e-05	0.000116	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	8.29e-05	0.000115	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—JAK2—Crohn's disease	8.29e-05	0.000115	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	8.18e-05	0.000114	CbGpPWpGaD
Promazine—DRD4—Signaling by GPCR—IL6—Crohn's disease	7.99e-05	0.000111	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	7.94e-05	0.00011	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—IL6—Crohn's disease	7.89e-05	0.00011	CbGpPWpGaD
Promazine—CHRM3—Metabolism—ALB—Crohn's disease	7.86e-05	0.000109	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.82e-05	0.000109	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—CXCL8—Crohn's disease	7.57e-05	0.000105	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—IL6—Crohn's disease	7.55e-05	0.000105	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	7.47e-05	0.000104	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TYK2—Crohn's disease	7.44e-05	0.000103	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—ALB—Crohn's disease	7.21e-05	0.0001	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—IL6—Crohn's disease	7.2e-05	9.99e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	7.12e-05	9.88e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	7.1e-05	9.86e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—JAK2—Crohn's disease	7.09e-05	9.85e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—PTGS2—Crohn's disease	6.87e-05	9.54e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	6.79e-05	9.43e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—STAT3—Crohn's disease	6.76e-05	9.39e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—STAT3—Crohn's disease	6.67e-05	9.26e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TYK2—Crohn's disease	6.56e-05	9.11e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	6.48e-05	8.99e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TYK2—Crohn's disease	6.46e-05	8.97e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TYK2—Crohn's disease	6.44e-05	8.95e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TYK2—Crohn's disease	6.42e-05	8.92e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TYK2—Crohn's disease	6.4e-05	8.89e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—STAT3—Crohn's disease	6.39e-05	8.87e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TYK2—Crohn's disease	6.34e-05	8.8e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	6.32e-05	8.78e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—PTGS2—Crohn's disease	6.31e-05	8.76e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—JAK2—Crohn's disease	6.26e-05	8.69e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	6.2e-05	8.61e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—JAK2—Crohn's disease	6.16e-05	8.55e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—IL6—Crohn's disease	6.16e-05	8.55e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—JAK2—Crohn's disease	6.15e-05	8.53e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—JAK2—Crohn's disease	6.13e-05	8.51e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—JAK2—Crohn's disease	6.11e-05	8.48e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—STAT3—Crohn's disease	6.09e-05	8.45e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—JAK2—Crohn's disease	6.05e-05	8.4e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	6.03e-05	8.38e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	6.01e-05	8.34e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	5.89e-05	8.18e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	5.88e-05	8.16e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CXCL8—Crohn's disease	5.71e-05	7.93e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	5.62e-05	7.81e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CXCL8—Crohn's disease	5.61e-05	7.79e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	5.61e-05	7.78e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	5.59e-05	7.76e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	5.57e-05	7.74e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	5.52e-05	7.66e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	5.51e-05	7.64e-05	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—IL6—Crohn's disease	5.43e-05	7.54e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—IL6—Crohn's disease	5.35e-05	7.42e-05	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—IL6—Crohn's disease	5.34e-05	7.41e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—IL6—Crohn's disease	5.32e-05	7.38e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—IL6—Crohn's disease	5.3e-05	7.36e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—IL6—Crohn's disease	5.25e-05	7.29e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	5.24e-05	7.27e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—STAT3—Crohn's disease	5.21e-05	7.23e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	5.12e-05	7.1e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—ALB—Crohn's disease	5.11e-05	7.09e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	4.98e-05	6.92e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	4.86e-05	6.75e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—IL6—Crohn's disease	4.72e-05	6.56e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—IL6—Crohn's disease	4.66e-05	6.47e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—ALB—Crohn's disease	4.66e-05	6.47e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—STAT3—Crohn's disease	4.6e-05	6.38e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—STAT3—Crohn's disease	4.52e-05	6.28e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—STAT3—Crohn's disease	4.51e-05	6.26e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—STAT3—Crohn's disease	4.5e-05	6.24e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—STAT3—Crohn's disease	4.48e-05	6.22e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PTGS2—Crohn's disease	4.47e-05	6.2e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—IL6—Crohn's disease	4.46e-05	6.19e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—STAT3—Crohn's disease	4.44e-05	6.16e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	4.43e-05	6.15e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—IL6—Crohn's disease	4.25e-05	5.9e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—IL6—Crohn's disease	4.2e-05	5.82e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	4.11e-05	5.71e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PTGS2—Crohn's disease	4.07e-05	5.66e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—ALB—Crohn's disease	3.98e-05	5.53e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—IL6—Crohn's disease	3.64e-05	5.05e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PTGS2—Crohn's disease	3.48e-05	4.83e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—IL6—Crohn's disease	3.48e-05	4.83e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—IL6—Crohn's disease	3.21e-05	4.46e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—IL6—Crohn's disease	3.16e-05	4.39e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—IL6—Crohn's disease	3.15e-05	4.38e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—IL6—Crohn's disease	3.14e-05	4.36e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—IL6—Crohn's disease	3.13e-05	4.35e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—IL6—Crohn's disease	3.1e-05	4.31e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—IL6—Crohn's disease	3.09e-05	4.29e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ALB—Crohn's disease	3.07e-05	4.26e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL6—Crohn's disease	2.87e-05	3.99e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.69e-05	3.73e-05	CbGpPWpGaD
